Abstract
We present management strategies utilised for the first case of an urgent live-donor ABO incompatible B blood group renal transplant, in a patient with a prior A blood group lung transplant for cystic fibrosis. Three years on, renal function is excellent and stable, whilst lung function has improved.
Keywords:
ABO blood group incompatibility; End-stage kidney disease; Lung transplantation; Renal transplantation.
Copyright © 2016 Elsevier B.V. All rights reserved.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
ABO Blood-Group System / immunology*
-
Acute Disease
-
Adult
-
Cystic Fibrosis / therapy*
-
Disease-Free Survival
-
Female
-
Graft Rejection / drug therapy
-
Graft Rejection / immunology*
-
HLA Antigens / immunology
-
Humans
-
Isoantigens / immunology*
-
Kidney Failure, Chronic / therapy*
-
Kidney Transplantation*
-
Living Donors
-
Lung Transplantation*
-
Middle Aged
-
Mothers
-
Mycophenolic Acid / therapeutic use
-
Plasmapheresis
-
Prednisolone / therapeutic use
-
Sepsis / therapy*
-
Tacrolimus / therapeutic use
-
Withholding Treatment
Substances
-
ABO Blood-Group System
-
HLA Antigens
-
Isoantigens
-
Prednisolone
-
Mycophenolic Acid
-
Tacrolimus